Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Llanos
Edwin Llanos, Kanata CA
| Patent application number | Description | Published |
|---|---|---|
| 20080200208 | Radio Accessory for a Mobile Device - A system for enhancing functionality of a mobile device comprising: the mobile device, wherein the mobile device includes: a radio subsystem; a processor adapted to interact with the radio subsystem; a user interface; a short range communications system; and a battery adapted to power the mobile device; and an accessory adapted to communicate with the mobile device, the accessory including: at least one processor; a radio subsystem communicating with the processor; and a short range communications system adapted to communicate with the short range communications system of the mobile device, wherein the radio subsystem of the mobile device differs from the radio subsystem of the accessory. | 08-21-2008 |
Gerald H. Llanos, Stewartsville, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20120029475 | Drug Combinations Useful for Prevention of Restenosis - The current invention comprises an approach to solving the clinical problem of restenosis, which involves the administration of combinations of drugs to patients undergoing PTCA or stent implantation. In one embodiment of the invention, an antiproliferative agent such as rapamycin, vincristine or taxol is administered in combination with the anti-inflammatory agent, dexamethasone, to patients systemically, either subcutaneously or intravenously. In another embodiment of the invention, the antiproliferative and anti-inflammatory agents are bound in a single formulation to the surface of a stent by means of incorporation within either a biodegradeable or biostable polymeric coating. Alternatively, such drug combinations could be incorporated into a stent constructed with a grooved reservoir. | 02-02-2012 |
Gerard Llanos, Stewartsville, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080228428 | SYSTEM AND METHOD FOR THE NON-DESTRUCTIVE ASSESSMENT OF THE QUANTITATIVE SPATIAL DISTRIBUTION OF COMPONENTS OF A MEDICAL DEVICE - A method and system for the non-destructive analysis of medical devices uses a confocal Raman microscope and other non-destructive analytical tools to assess the spatial distribution of components of an object such as the distribution of an active pharmaceutical ingredient (API) within a polymer matrix. In a preferred embodiment, confocal Raman spectroscopy was used to differentiate each component found in the sirolimus-eluting coronary stent. The unique spectral features identified for each component were then used to develop three separate calibration curves to describe the solid phase distribution found on drug-polymer coated stents. The calibration curves were obtained by analyzing confocal Raman spectral depth profiles from a set of 16 unique formulations of drug-polymer coatings sprayed onto stents and planar substrates. | 09-18-2008 |
| 20110086175 | Process and Apparatus for Coating a Porous Substrate with a Coating Liquid - An engagement head for engaging a porous substrate includes at least two pin sets, each pin set including a plurality of pins arranged in a plurality of parallel pin rows at a predetermined pin angle, wherein pins of immediately neighboring pin rows are arranged such that pin angles for the pins in a pin row are inversely symmetrical to pin angles for the pins in a neighboring pin row. The pins of a pin row move collectively in the same direction when a pin set is extended, which direction is determined by the pin angle of the pin row, whereby neighboring pin rows move in opposite longitudinal directions from one another when the pin set is extended. The pin sets may be extended and retracted in unison by a single actuation source. | 04-14-2011 |
Gerard H. Llanos, Stewartsville, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080317827 | Methods and Devices for Delivering Therapeutic Agents to Target Vessels - Methods of preparing devices for delivering at least one therapeutic agent to a target vessel in a mammal, the devices prepared by such methods, and uses of such devices for delivering a therapeutic agent, such as an antiproliferative agent, to a target vessel. | 12-25-2008 |
| 20090204204 | Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease - A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity. | 08-13-2009 |
| 20100239636 | Methods and Devices for Delivering Therapeutic Agents to Target Vessels - Methods of preparing devices for delivering at least one therapeutic agent to a target vessel in a mammal, the devices prepared by such methods, and uses of such devices for delivering a therapeutic agent, such as an antiproliferative agent, to a target vessel. | 09-23-2010 |
| 20100268329 | Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease - A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity. | 10-21-2010 |
| 20100285089 | Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon - Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In particular, disclosed herein is a drug delivery device comprising a balloon-expandable intraluminal stent, and a pharmaceutical agent-containing coating, wherein the coating comprises a biocompatible polyfluoro copolymer that comprises about eighty-five weight percent vinylidinefluoride copolymerized with about fifteen weight percent hexafluoropropylene and a pharmaceutical agent intermixed with said polyfluoro copolymer. | 11-11-2010 |
| 20110177152 | Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease - A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity. | 07-21-2011 |